^
Association details:
Evidence:
Evidence Level:
Sensitive: A1 - Approval
Published date:
11/20/2018
Excerpt:
Apealea in combination with carboplatin is indicated for the treatment of adult patients with first relapse of platinum‑sensitive epithelial ovarian cancer, primary peritoneal cancer and fallopian tube cancer.